Primary cicatricial alopecia : Other lymphocytic primary cicatricial alopecias and neutrophilic and mixed primary cicatricial alopecias - 14/11/16

Doi : 10.1016/j.jaad.2015.01.056

Chantal Bolduc, MD, FRCPC ^a,^⁎ , Leonard C. Sperling, MD ^b,^c, Jerry Shapiro, MD, FRCPC ^d,^e
^a Department of Dermatology, University of Montreal, Montreal, Quebec, Canada
^b Department of Dermatology, Uniformed Services University of the Health Sciences, Bethesda, Maryland
^c Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland
^d Department of Dermatology, University of British Columbia, Vancouver, British Columbia, Canada
^e Department of Dermatology, New York University, New York, New York

^∗Reprint requests: Chantal Bolduc, MD, FRCPC, Innovaderm Research, Inc, 1851 Sherbrooke E, Ste 502, Montreal, QC H2K 4L5.

Abstract

Primary cicatricial alopecias can be frustrating for both patients and physicians. Proper diagnosis guides more successful management of these challenging conditions. Part II will cover the remaining lymphocytic primary cicatricial alopecias, which include pseudopelade of Brocq, central centrifugal cicatricial alopecia, alopecia mucinosa, and keratosis follicularis spinulosa decalvans. It will also discuss the neutrophilic and mixed primary cicatricial alopecias, namely folliculitis decalvans, dissecting cellulitis, folliculitis keloidalis, folliculitis (acne) necrotica, and erosive pustular dermatosis.

Le texte complet de cet article est disponible en PDF.

Key words : alopecia, cicatricial, fibrosis, follicles, hair, hair loss, lymphocytes, neutrophils, permanent

Abbreviations used : AANS, AM, CCCA, DC, EPD, FD, FK, FM, FN, ITA, FKSD, LPP, MMF, PCA, PDIRS, PDT, PPB, TF

Plan

Pseudopelade of Brocq pattern of cicatricial alopecia

Central centrifugal cicatricial alopecia

Alopecia mucinosa/follicular mucinosis

Keratosis follicularis spinulosa decalvans

Folliculitis decalvans

Dissecting cellulitis

Folliculitis keloidalis

Folliculitis necrotica

Erosive pustular dermatosis

	Dr Bolduc has been a speaker for Johnson and Johnson. Dr Shapiro has been a speaker for, consultant for, or has received honoraria from Merck, Johnson and Johnson, Dr Reddy, and Applied Biology. He is a cofounder of, has stock options in, and is a stockholder for Replicel. Dr Sperling has no conflicts of interest to declare.
	Date of release: December 2016
	Expiration date: December 2019